GlaxoSmithKline PLC Director/PDMR Shareholding (7867I)
June 21 2017 - 8:35AM
UK Regulatory
TIDMGSK
RNS Number : 7867I
GlaxoSmithKline PLC
21 June 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Mrs V A Whyte
=== ======================== ===========================================
b) Position/status Company Secretary
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each "Ordinary
the financial Shares"
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the The exercise of options over 4,820 Ordinary
transaction Shares, granted on 19 February 2008 under
the GlaxoSmithKline 2001 Share Option Plan
- UK Unapproved Trust.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- ----------
GBP11.47 4,820
---------- ----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2017-06-20
=== ======================== ===========================================
f) Place of the n/a
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mrs V A Whyte
=== ======================== ===============================================
b) Position/status Company Secretary
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of Ordinary shares of 25 pence each "Ordinary
the financial Shares"
instrument ISIN: GB0009252882
=== ======================== ===============================================
b) Nature of the The sale of 4,820 Ordinary Shares following
transaction the exercise of options granted on 19 February
2008 under the GlaxoSmithKline 2001 Share
Option Plan - UK Unapproved Trust.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- ----------
GBP16.93 4,820
---------- ----------
=== ======================== ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===============================================
e) Date of the transaction 2017-06-20
=== ======================== ===============================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHXFLFLDQFXBBZ
(END) Dow Jones Newswires
June 21, 2017 09:35 ET (13:35 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024
